Evaluation of a screening strategy after occurence of two simultaneous contaminating tuberculosis cases in a pediatric oncology department;Stratégie de prise en charge de contages tuberculeux dans un service d'oncologie-pédiatrique

Archives de Pediatrie

Volumn 15, Issue 3, 2008, Pages 236-244

  Gauchon, A ^a   Andre N ^a   Rome, A ^a   Lautraite, C ^a   Coze, C ^a   Gentet, J C ^a   Dubus, J C ^b   Bernard, J L ^a  

^a TIMONE HOSPITAL   (France)

^b EA3287   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MONITORING; CANCER CHEMOTHERAPY; CANCER SCREENING; CHILD; CHILDHOOD CANCER; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; NEWBORN SCREENING; PROPHYLAXIS; RADIOLOGICAL PROCEDURES; SOLID TUMOR; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULOSIS;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; STEM CELL TRANSPLANTATION; TUBERCULOSIS, PULMONARY;

EID: 41449095363     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.01.005     Document Type: Article

References (32)

1. Gaudelus J., and De Pontual L. Épidémiologie de la tuberculose en France. Arch Pediatr 12 (2005) 83-87
2. Delacourt C. Facteurs de risque de tuberculose chez l'enfant. Arch Pediatr 12 (2005) 80-82
3. Jasmer R.M., Nahid P., and Hopewell P.C. Clinical practice: latent tuberculosis infection. N Engl J Med 347 (2002) 1860-1866
4. Akhila K., Mahadevan S., and Adhisivam B. Qualitative evaluation of tuberculin test responses in childhood tuberculosis. Indian J Pediatr 74 (2007) 641-644
5. Tissot F., Zanetti G., Francioli P., et al. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size?. Clin Infect Dis 40 (2005) 211-217
6. Albertini M. Traitement de la tuberculose. Arch Pediatr 12 (2005) 110-116
7. Deschildre A., Poirier C., and Cadranel J. Recommandations de la Société de pneumologie de langue française pour la prise en charge de la tuberculose en France 2004. Rev Mal Respir 21 (2004) 98-104
8. Hussain Z., Kar P., and Hussain S.A. Antituberculosis drugs-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol 41 (2003) 1226-1232
9. Yee D., Valiquette C., Pelletier M., et al. Incidence of serious side effects from first-Line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 167 (2003) 1472-1477
10. Frappaz D., Biron P., Biron E., et al. Severe neurological toxicity secondary to the association of accidental poisoning by isionazid and a protocol containing high dose of vincristine. Pediatrics 39 (1984) 133-140
11. Zelunka E.J. Intravenous cyclosporine-rifampin interaction in a pediatric bone marrow transplant recipient. Pharmacotherapy 22 (2002) 387-390
12. Yonemori K., Takeda Y., Toyota E., et al. Potentiel interactions between irinotecan and rifampin in a patient with small-cell lung cancer. Int J Clin Oncol 9 (2004) 206-209
13. Ohkawa K., Hashiguchi M., Ohno K., et al. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients. Clin Pharmacol Ther 72 (2002) 220-226
14. Waecker N.J., Stefanova R., Cave M.D., et al. Nosocomial transmission of mycobacterium bovis bacille Calmette-Guerin to children receiving cancer therapy and to their health care providers. Clin Infect Dis 30 (2000) 356-362
15. Vos M.C., de Haas P.E., Verbrugh H.A., et al. Nosocomial mycobacterium bovis-bacille Calmette-Guerin infections due to contamination of chemotherapeutics: case finding and route of transmission. J Infect Dis 188 (2003) 1332-1335
16. Aisenberg G.M., Jacobson K., Chemaly R.F., et al. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: mycobacterium tuberculosis disease in patients at a comprehensive cancer center (2001-2005). Cancer 104 (2005) 2882-2887
17. Fallo A., De Matteo E., Preciado M.V., et al. Epstein-Barr virus associated with primary CNS lymphoma and disseminated BCG infection in a child with AIDS. Int J Infect Dis 9 (2005) 96-103
18. Kornreich L., Goshen Y., Horev G., et al. Mycobacterial respiratory infection in leukemic children. Eur J Radiol 21 (1995) 44-46
19. Saarinen U.M. Severe infections in childhood leukaemia. A follow-up study of 100 consecutive ALL patients. Acta Paediatr Scand 73 (1984) 515-522
20. Klossek A., Dannenberg C., Feuerhahn M.R., et al. Pulmonary tuberculosis in a child receiving intensive chemotherapy for acute myeloblastic leukemia. J Pediatr Hematol Oncol 26 (2004) 64-67
21. Menon B.S., Maziah W., Aiyar S., et al. Disseminated tuberculosis in acute leukemia. Pediatr Int 43 (2001) 161-163
22. Chen C.C., Huang L.M., Chang Y.L., et al. Acute respiratory distress syndrome due to tuberculosis in a child after allogenic bone marrow transplantation for acute lymphoblastic leukemia. J Formos Med Assoc 98 (1999) 701-704
23. Stone M.M., and Vanier A.M. Brief report: meningitis due to iatrogenic BCG infection in two immunocompromised children. N Engl J Med 333 (1995) 561-563
24. Kim D.K., Lee S.W., Yoo C.G., et al. Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy. Chest 128 (2005) 2218-2222
25. Tufariello J., Chan J., and Flynn J.L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3 (2003) 578-590
26. Wessels G., Hesseling P.B., Gie R.P., et al. The increased risk of developing tuberculosis in children with malignancy. Ann Trop Paediatr 12 (1992) 277-281
27. Karakas Z., Agaoglu L., Taravari B., et al. Pulmonary tuberculosis in children with Hodgkin's lymphoma. Hematol J 4 (2003) 78-81
28. Fountain F.F., Tolley E., Chrisman C.R., et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection. Chest 128 (2005) 116-123
29. Sanfeliu C., Wright J.M., and Kim S.U. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line. Neurotoxicology 20 (1999) 935-944
30. Forget E.J., and Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf 5 (2006) 231-249
31. Blanc P., Minodier P., Dubus J.C., et al. Les nouveaux tests diagnostiques de la tuberculose. Rev Mal Respir 24 (2007) 441-452
32. Herrmann J.L., Simonney N., and Lagrange P.H. Avantages et limites des tests sanguins in vitro lymphocytes T/interféron gamma comparativement au test intradermique à la tuberculine pour le diagnostic de tuberculose. Arch Pediatr 14 (2007) 207-211